EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Optic nerve diseases and regeneration: How far are we from the promised land?

Ling-Ping Cen iD, Kevin K Park iD, Kowk-Fai So iD

Clinical & Experimental Ophthalmology · 2023-08 · 51 (6) · 627-641

DOI: 10.1111/ceo.14259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical & Experimental Ophthalmology, online erschienen am 15.06.2023. Verfasst von Ling-Ping Cen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuro-Ophthalmology, Joint Shantou International Eye Centre of Shantou University and The Chinese University of Hong Kong, Shantou, Gua…. Hauptthemen laut MEDLINE: Optic Nerve Injuries, Optic Nerve Diseases. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The retinal ganglion cells (RGCs) are the sole output neurons that connect information from the retina to the brain. Optic neuropathies such as glaucoma, trauma, inflammation, ischemia and hereditary optic neuropathy can cause RGC loss and axon damage, and lead to partial or total loss of vision, which is an irreversible process in mammals. The accurate diagnoses of optic neuropathies are crucial for timely treatments to prevent irrevocable RGCs loss. After severe ON damage in optic neuropathies, promoting RGC axon regeneration is vital for restoring vision. Clearance of neuronal debris, decreased intrinsic growth capacity, and the presence of inhibitory factors have been shown to contribute to the failure of post‐traumatic CNS regeneration. Here, we review the current understanding of manifestations and treatments of various common optic neuropathies. We also summarise the current known mechanisms of RGC survival and axon regeneration in mammals, including specific intrinsic signalling pathways, key transcription factors, reprogramming genes, inflammation‐related regeneration factors, stem cell therapy, and combination therapies. Significant differences in RGC subtypes in survival and regenerative capacity after injury have also been found. Finally, we highlight the developmental states and non‐mammalian species that are capable of regenerating RGC axons after injury, and cellular state reprogramming for neural repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic Nerve InjuriesOptic Nerve DiseasesHumansAnimalsAxonsNerve RegenerationMammals

Stichwörter der Autor:innen

axon regenerationoptic nerve injuryoptic neuropathiesretinal ganglion cellssurvival

Autor:innen und Institutionen

  • Department of Neuro-Ophthalmology, Joint Shantou International Eye Centre of Shantou University and The Chinese University of Hong Kong, Shantou, Guangdong, China.
  • Shantou University Medical College, Shantou, Guangdong, China.
  • Department of Neurological Surgery, The Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Guangzhou-HongKong-Macau Institute of CNS Regeneration, Jinan University, Guangzhou, China.
  • Aier School of Ophthalmology, Changsha Aier Hospital of Ophthalmology, Changsha, China.

ORCID-Profile: Ling-Ping Cen, Kevin K Park, Kowk-Fai So

Förderung

  • NEI NIH HHS
  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Cen, L. P., Park, K. K., & So, K. F. (2023). Optic nerve diseases and regeneration: How far are we from the promised land?. Clinical & Experimental Ophthalmology, 51(6), 627-641. https://doi.org/10.1111/ceo.14259

Vancouver

Cen LP, Park KK, So KF. Optic nerve diseases and regeneration: How far are we from the promised land?. Clinical & Experimental Ophthalmology. 2023;51(6):627-641. doi:10.1111/ceo.14259

BibTeX
@article{Cen2023,
  author = {Cen, Ling-Ping and Park, Kevin K and So, Kowk-Fai},
  title = {Optic nerve diseases and regeneration: How far are we from the promised land?},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2023},
  volume = {51},
  number = {6},
  pages = {627--641},
  doi = {10.1111/ceo.14259}
}
Kostenlos starten →